₹ 2,590.00
108.20 (4.36%)
G
Glenmark Pharmaceuticals
₹ 2,590.00
Glenmark Pharmaceuticals Fundamentals
Company Valuation
Market Cap (₹ Cr.)
73,096
PE Ratio
39.00
PB Ratio
6.67
Dividend Yield
0.20%
ROE
12.96%
ROCE
16.21%
Book Value (₹)
372.47
Face Value (₹)
1.00
Analyse GLENMARK with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 46.65% | 46.65% | 46.65% | 46.65% | 46.65% |
| Domestic Institutional Investors (DII) | 18.61% | 20.09% | 19.29% | 18.60% | 17.64% |
| Foreign Institutional Investors (FII) | 20.73% | 19.20% | 20.34% | 20.89% | 21.51% |
| Public Investors | 10.81% | 10.77% | 10.32% | 10.60% | 10.44% |
| Government | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
GLENMARK Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals & Biotechnology
Company Classification
Midcap
BSE Scrip Code
532296
NSE Scrip Name
GLENMARK
ISIN
INE935A01035
Part of Indices

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






